# An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

> **NCT00358631** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 319 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** SSR149415

## Key facts

- **NCT ID:** NCT00358631
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2009-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358631, "An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00358631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*